|
1
|
Sawyer RA, Selhorst JB, Zimmerman LE and
Hoyt WF: Blindness caused by photoreceptor degeneration as a remote
effect of cancer. Am J Ophthalmol. 81:606–613. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singh D and Tripathy K: Cancer Associated
Retinopathy-StatPearls-NCBI Bookshelf. StatPearls Publishing.
(Treasure Island, FL). 2023.
|
|
3
|
Jacobson DM, Thirkill CE and Tipping SJ: A
clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol.
28:162–167. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guy J and Aptsiauri N: Treatment of
paraneoplastic visual loss with intravenous immunoglobulin: report
of 3 cases. Arch Ophthalmol. 117:471–477. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ramos-Ruperto L, Busca-Arenzana C, Boto-de
los Bueis A, Schlincker A, Arnalich-Fernández F and
Robles-Marhuenda Á: Cancer-associated retinopathy and treatment
with intravenous immunoglobulin therapy. A seldom used approach?
Ocul Immunol Inflamm. 29:399–402. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dimitriou E, Chatzirallis A, Katopodis S,
Theodossiadis G, Theodossiadis P and Chatziralli I:
Cancer-associated retinopathy 4 years after surgery for ovarian
cancer. Oman J Ophthalmol. 14:108–111. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heckenlively JR and Ferreyra HA:
Autoimmune retinopathy: A review and summary. Semin Immunopathol.
30:127–134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Makiyama Y, Kikuchi T, Otani A, Oishi A,
Guo C, Nakagawa S, Ogino K, Kojima H, Kurimoto M and Yoshimura N:
Clinical and immunological characterization of paraneoplastic
retinopathy. Invest Ophthalmol Vis Sci. 54:5424–5431. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khan N, Huang JJ and Foster CS: Cancer
associated retinopathy (CAR): An autoimmune-mediated paraneoplastic
syndrome. Semin Ophthalmol. 21:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thirkill CE, Roth AM and Keltner JL:
Cancer-associated retinopathy. Arch Ophthalmol. 105:372–375. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Polans AS, Witkowska D, Haley TL, Amundson
D, Baizer L and Adamus G: Recoverin, a photoreceptor-specific
calcium-binding protein, is expressed by the tumor of a patient
with cancer-associated retinopathy. Proc Natl Acad Sci USA.
92:91761995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Adamus G: Autoantibody-induced apoptosis
as a possible mechanism of autoimmune retinopathy. Autoimmun Rev.
2:63–68. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Magrys A, Anekonda T, Ren G and Adamus G:
The role of anti-alpha-enolase autoantibodies in pathogenicity of
autoimmune-mediated retinopathy. J Clin Immunol. 27:181–192. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adamus G, Aptsiauri N, Guy J, Heckenlively
J, Flannery J and Hargrave PA: The occurrence of serum
autoantibodies against enolase in cancer-associated retinopathy.
Clin Immunol Immunopathol. 78:120–129. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren G and Adamus G: Cellular targets of
anti-alpha-enolase autoantibodies of patients with autoimmune
retinopathy. J Autoimmun. 23:161–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ko AC, Brinton JP, Mahajan VB, Zimmerman
B, Brinton GS, Stone EM, Folk JC and Mullins RF: Seroreactivity
against aqueous-soluble and detergent-soluble retinal proteins in
posterior uveitis. Arch Ophthalmol. 129:415–420. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grewal DS, Fishman GA and Jampol LM:
Autoimmune retinopathy and antiretinal antibodies: A review.
Retina. 34:827–845. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mahdi N, Faia LJ, Goodwin J, Nussenblatt
RB and Nida Sen H: A case of autoimmune retinopathy associated with
thyroid carcinoma. Ocul Immunol Inflamm. 18:322–323. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Or C, Collins DR, Merkur AB, Wang Y, Chan
CC and Forooghian F: Intravenous rituximab for the treatment of
cancer-associated retinopathy. Can J Ophthalmol. 48:e35–e38. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dy I, Chintapatla R, Preeshagul I and
Becker D: Treatment of cancer-associated retinopathy with
rituximab. J Natl Compr Canc Netw. 11:1320–1324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davoudi S, Ebrahimiadib N, Yasa C, Sevgi
DD, Roohipoor R, Papavasilieou E, Comander J and Sobrin L: Outcomes
in autoimmune retinopathy patients treated with rituximab. Am J
Ophthalmol. 180:124–132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Turaka K, Kietz D, Krishnamurti L,
Mitchell E, Scanga H, Fu VLN and Sylvester C: Carcinoma-associated
retinopathy in a young teenager with immature teratoma of the
ovary. J AAPOS. 18:396–398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roels D, Ueno S, Talianu CD, Draganova D,
Kondo M and Leroy BP: Unilateral cancer-associated retinopathy:
Diagnosis, serology and treatment. Doc Ophthalmol. 135:233–240.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Magro C, Loewenstein JI, Makar RS,
Stowell CP, Dzik WH, Hochberg EP, Oaklander AL and Sobrin L: A man
with paraneoplastic retinopathy plus small fiber polyneuropathy
associated with Waldenström macroglobulinemia (Lymphoplasmacytic
Lymphoma): Insights into mechanisms. Ocul Immunol Inflamm.
23:405–409. 2015. View Article : Google Scholar : PubMed/NCBI
|
